Additional file:
Open peer review report 2 on "The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis". Reviewer: Paulina Carriba, Cardiff University, UK Comments to the author: This perspective article shows how different could be the progression of Alzheimer's disease, pointing that such differences could be related to different proteomic alterations. Using a localized proteomics technique, that the authors have developed, in which combines laser capture microdissection (LCM) and label-free quantitave LC-MS, the authors are able to analyse the expression of hundreds of proteins using formalin-fixed paraffin embedded (FFPE) tissue.
The article is principally very interesting, both for the introduction of the localized proteomics technique and for the important findings in AD pathogenesis. The manuscript is well-organized and correctly written. However, some minor points have to be amended. 1. It is necessary to include any reference after the following sentences: a. "This is consistent with GWAS data suggestion the involvement of multiple different pathways upstream from plaques and NFTs." Page 2, line 23 b. "…, consistent with what has been hypothesized in recent studies." Page 4, line 52 2. Considering the important results the authors have found using the technique of localized proteomics in FFPE blocks, it makes such procedure highly attractive to implement, especially in clinic where huge quantities of FFPE blocks of patients are storage. The paper shows how potent could be the technique, but a further discussion of what could be the weak points or the problems associated (controls, validity of the results,… ) would be really required.
Open peer review report 3 on "The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis". Reviewer: Marvin Antonio, Escuela Superrior de Medicina IPN, Mexico Comments to the author: The manuscript is interesting and focused in the scope of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis. I suggest to add, at least in brief, data regarding the main pioneer works related to localized proteomics in CNS-diseases, as well as the relevance of this technique to prevention and diagnosis of AD and other maladies. The manuscript is biased to your findings, however, some work of other authors in these fields (localized proteomics in CSN, techniques for analysis of CNS-Tissue, the main protein-targets in these applications, assays in animal models of neurodegenerative diseases showing differential proteomics) should be considered. Finally, I suggest the building of a clear state-of-art section previously to the last paragraph (as a conclusion of the current advances).
